Breaking News Instant updates and real-time market news.

SNA

Snap-On

$157.57 /

+0.25 (+0.16%)

12:20
05/24/19
05/24
12:20
05/24/19
12:20

Bullish call spread in Snap On will create its biggest open interest

Bullish call spread in Snap On will create its biggest open interest. The stock off 19c to $157.13 and 400 Jun 160 - 165 call spreads trade $1.70 on ISE. A customer bought the vertical and it has traded 2.2K total today. Position size is notable, since Snap on has just 6.6K aggregate OI across all strikes, and it's a bullish play with a max payout on a four-week 4.7% move to $165 or better. Earnings last reported 4/18, sending shares up 6.5% to $168.07, and not due again until mid-July. September 52-week high is $188.46.

  • 30

    May

  • 05

    Jun

SNA Snap-On
$157.57 /

+0.25 (+0.16%)

04/18/19 Barrington
Barrington encouraged after Snap-On's better than expected Q1
04/16/19 BofA
Snap-On downgraded to Neutral on decelerating growth at BofA/Merrill
04/16/19 BofA
Snap-On downgraded to Neutral from Buy at BofA/Merrill
04/10/19 Baird
Snap-On downgraded to Neutral from Outperform at Baird

TODAY'S FREE FLY STORIES

Initiation
Teladoc initiated with a Buy at Argus » 07:07
07/13/20
07/13
07:07
07/13/20
07:07
TDOC

Teladoc

$229.30 /

+0.66 (+0.29%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

07/06/20 Stephens
Teladoc initiated with an Overweight at Stephens
06/30/20 Piper Sandler
Virtual care market to benefit from PHE extension, says Piper Sandler
06/30/20 Piper Sandler
Piper survey shows over 10 times increase in telemedicine utilization
06/05/20 Piper Sandler
Teladoc price target raised to $220 from $212 at Piper Sandler
TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

Hot Stocks
Yamana sees Q2 gold productio 164,141 ounces, silver production 2.01M ounces » 07:07
07/13/20
07/13
07:07
07/13/20
07:07
AUY

Yamana Gold

$5.51 /

-0.085 (-1.52%)

YAMANA GOLD announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

05/22/20 National Bank
Yamana Gold downgraded to Sector Perform from Outperform at National Bank
04/16/20 Scotiabank
Yamana Gold upgraded to Outperform from Sector Perform at Scotiabank
02/11/20 Stifel
Stifel upgrades Yamana to Buy on stronger position for 2020
02/11/20 Stifel
Yamana Gold upgraded to Buy from Hold at Stifel
AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

Recommendations
Biogen price target lowered to $257 from $300 at Goldman Sachs » 07:06
07/13/20
07/13
07:06
07/13/20
07:06
BIIB

Biogen

$279.05 /

+0.15 (+0.05%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$279.05 /

+0.15 (+0.05%)

BIIB Biogen
$279.05 /

+0.15 (+0.05%)

07/08/20 Credit Suisse
Biogen submits Aducanumab BLA, upside possible near-term, says Credit Suisse
07/08/20 Stifel
Biogen submission of Aducanumab BLA 'an incremental positive,' says Stifel
07/08/20 Goldman Sachs
Goldman says Biogen BLA submission for Alzheimer's drug an incremental positive
07/08/20 Jefferies
Biogen likely to get Priority Review for aducanumab, says Jefferies
BIIB Biogen
$279.05 /

+0.15 (+0.05%)

BIIB Biogen
$279.05 /

+0.15 (+0.05%)

BIIB Biogen
$279.05 /

+0.15 (+0.05%)

BIIB Biogen
$279.05 /

+0.15 (+0.05%)

Hot Stocks
Axsome Therapeutics completes FDA pre-NDA meeting for AXS-05 » 07:05
07/13/20
07/13
07:05
07/13/20
07:05
AXSM

Axsome Therapeutics

$83.02 /

+1.06 (+1.29%)

Axsome Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$83.02 /

+1.06 (+1.29%)

AXSM Axsome Therapeutics
$83.02 /

+1.06 (+1.29%)

04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
04/28/20 H.C. Wainwright
Axsome Therapeutics price target raised to $210 from $200 at H.C. Wainwright
AXSM Axsome Therapeutics
$83.02 /

+1.06 (+1.29%)

  • 19
    Dec
AXSM Axsome Therapeutics
$83.02 /

+1.06 (+1.29%)

AXSM Axsome Therapeutics
$83.02 /

+1.06 (+1.29%)

General news
FX Update: The dollar and yen had traded softer » 07:05
07/13/20
07/13
07:05
07/13/20
07:05

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Fisker to list on NYSE via merger with Spartan Energy Acquisition » 07:04
07/13/20
07/13
07:04
07/13/20
07:04
SPAQ

Spartan Energy Acquisition

$16.67 /

+1.715 (+11.47%)

, APO

Apollo Global

$50.10 /

+0.15 (+0.30%)

Fisker and Spartan Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPAQ Spartan Energy Acquisition
$16.67 /

+1.715 (+11.47%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

SPAQ Spartan Energy Acquisition
$16.67 /

+1.715 (+11.47%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
APO Apollo Global
$50.10 /

+0.15 (+0.30%)

  • 26
    Nov
APO Apollo Global
$50.10 /

+0.15 (+0.30%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

Initiation
Aptorum Group initiated with a Buy at Alliance Global Partners » 07:04
07/13/20
07/13
07:04
07/13/20
07:04
APM

Aptorum Group

$3.44 /

+ (+0.00%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APM Aptorum Group
$3.44 /

+ (+0.00%)

Hot Stocks
Virtus Investment reports preliminary total AUM $108.5B as of June 30 » 07:03
07/13/20
07/13
07:03
07/13/20
07:03
VRTS

Virtus Investment

$126.62 /

+6.235 (+5.18%)

The increase in long-term…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTS Virtus Investment
$126.62 /

+6.235 (+5.18%)

VRTS Virtus Investment
$126.62 /

+6.235 (+5.18%)

06/15/20 Barclays
Virtus Investment price target raised to $118 from $105 at Barclays
05/04/20 Barclays
Virtus Investment price target raised to $105 from $95 at Barclays
02/18/20 Piper Sandler
Virtus Investment price target raised to $155 from $144 at Piper Sandler
02/03/20 Barclays
Barclays upgrades Virtus Investment to Overweight on recent momentum
VRTS Virtus Investment
$126.62 /

+6.235 (+5.18%)

Hot Stocks
Fisker to list on NYSE via merger with Spartan Energy Acquisition  07:03
07/13/20
07/13
07:03
07/13/20
07:03
SPAQ

Spartan Energy Acquisition

$16.67 /

+1.715 (+11.47%)

, APO

Apollo Global

$50.10 /

+0.15 (+0.30%)

 
ShowHide Related Items >><<
APO Apollo Global
$50.10 /

+0.15 (+0.30%)

SPAQ Spartan Energy Acquisition
$16.67 /

+1.715 (+11.47%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
APO Apollo Global
$50.10 /

+0.15 (+0.30%)

  • 26
    Nov
APO Apollo Global
$50.10 /

+0.15 (+0.30%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

Hot Stocks
Benefytt Technologies to be acquired by MDP Funds for $31.00 per share » 07:02
07/13/20
07/13
07:02
07/13/20
07:02
BFYT

Benefytt Technologies

$22.38 /

+3.07 (+15.90%)

Benefytt Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BFYT Benefytt Technologies
$22.38 /

+3.07 (+15.90%)

BFYT Benefytt Technologies
$22.38 /

+3.07 (+15.90%)

07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
07/01/20 SVB Leerink
Benefytt Technologies initiated with an Outperform at SVB Leerink
06/30/20 Northland
Benefytt trades at 'large discount' to other MA players, says Northland
03/24/20 Lake Street
Benefytt well positioned in current environment, says Lake Street
BFYT Benefytt Technologies
$22.38 /

+3.07 (+15.90%)

BFYT Benefytt Technologies
$22.38 /

+3.07 (+15.90%)

BFYT Benefytt Technologies
$22.38 /

+3.07 (+15.90%)

Hot Stocks
Roche, Summit Cancer Centers to collaborate on use of new digital healthcare » 07:02
07/13/20
07/13
07:02
07/13/20
07:02
RHHBY

Roche

$0.00 /

+ (+0.00%)

Roche announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

06:01 Today Bernstein
Roche initiated with an Outperform at Bernstein
07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Upgrade
Pinnacle Renewable upgraded to Buy from Hold at Desjardins » 07:02
07/13/20
07/13
07:02
07/13/20
07:02
PINWF

Pinnacle Renewable

$0.00 /

+ (+0.00%)

Desjardins analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PINWF Pinnacle Renewable
$0.00 /

+ (+0.00%)

06/15/20 Scotiabank
Pinnacle Renewable upgraded to Outperform from Sector Perform at Scotiabank
05/15/20 Scotiabank
Pinnacle Renewable price target lowered to C$7.50 from C$9.50 at Scotiabank
05/14/20 RBC Capital
Pinnacle Renewable price target lowered to C$9 from C$12 at RBC Capital
05/13/20 Stifel
Pinnacle Renewable downgraded to Hold from Buy at Stifel
Recommendations
Retrophin price target lowered to $31 from $34 at BMO Capital » 07:00
07/13/20
07/13
07:00
07/13/20
07:00
RTRX

Retrophin

$20.04 /

-0.08 (-0.40%)

BMO Capital analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTRX Retrophin
$20.04 /

-0.08 (-0.40%)

RTRX Retrophin
$20.04 /

-0.08 (-0.40%)

06/16/20 BTIG
Retrophin initiated with a Buy at BTIG
02/25/20 Barclays
Retrophin downgraded to Equal Weight from Overweight at Barclays
01/13/20 JMP Securities
JMP says continues to like Retrophin opportunity
08/23/19 BMO Capital
Retrophin price target lowered to $33 from $38 at BMO Capital
RTRX Retrophin
$20.04 /

-0.08 (-0.40%)

  • 09
    Jun
Hot Stocks
Mednax reaches agreement with Starboard Value » 06:59
07/13/20
07/13
06:59
07/13/20
06:59
MD

Mednax

$17.67 /

+0.675 (+3.97%)

These announcements are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MD Mednax
$17.67 /

+0.675 (+3.97%)

MD Mednax
$17.67 /

+0.675 (+3.97%)

06/09/20 Mizuho
Mednax price target raised to $20 from $17 at Mizuho
06/08/20 BMO Capital
Mednax price target raised to $20 from $16 at BMO Capital
05/29/20 Mizuho
Mednax price target lowered to $17 from $19 at Mizuho
05/08/20 Deutsche Bank
Mednax price target lowered to $15 from $24 at Deutsche Bank
MD Mednax
$17.67 /

+0.675 (+3.97%)

MD Mednax
$17.67 /

+0.675 (+3.97%)

Hot Stocks
Mednax board appoints five new directors » 06:58
07/13/20
07/13
06:58
07/13/20
06:58
MD

Mednax

$17.67 /

+0.675 (+3.97%)

The company announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MD Mednax
$17.67 /

+0.675 (+3.97%)

MD Mednax
$17.67 /

+0.675 (+3.97%)

06/09/20 Mizuho
Mednax price target raised to $20 from $17 at Mizuho
06/08/20 BMO Capital
Mednax price target raised to $20 from $16 at BMO Capital
05/29/20 Mizuho
Mednax price target lowered to $17 from $19 at Mizuho
05/08/20 Deutsche Bank
Mednax price target lowered to $15 from $24 at Deutsche Bank
MD Mednax
$17.67 /

+0.675 (+3.97%)

MD Mednax
$17.67 /

+0.675 (+3.97%)

Hot Stocks
Lannett announces restructuring, cost reduction initiatives, will cut 80 jobs » 06:57
07/13/20
07/13
06:57
07/13/20
06:57
LCI

Lannett

$5.74 /

-0.45 (-7.27%)

Lannett announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LCI Lannett
$5.74 /

-0.45 (-7.27%)

LCI Lannett
$5.74 /

-0.45 (-7.27%)

07/10/20 Raymond James
Raymond James lowers Lannett forecasts on fluphenazine competition
09/18/19 SunTrust
Lannett price target raised to $14 from $10 at SunTrust
08/29/19 SunTrust
Lannett price target raised to $10 from $7 at SunTrust
LCI Lannett
$5.74 /

-0.45 (-7.27%)

Hot Stocks
Mednax names Mark Ordan CEO, succeeding Roger Medel, M.D » 06:57
07/13/20
07/13
06:57
07/13/20
06:57
MD

Mednax

$17.67 /

+0.675 (+3.97%)

Mednax announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MD Mednax
$17.67 /

+0.675 (+3.97%)

MD Mednax
$17.67 /

+0.675 (+3.97%)

06/09/20 Mizuho
Mednax price target raised to $20 from $17 at Mizuho
06/08/20 BMO Capital
Mednax price target raised to $20 from $16 at BMO Capital
05/29/20 Mizuho
Mednax price target lowered to $17 from $19 at Mizuho
05/08/20 Deutsche Bank
Mednax price target lowered to $15 from $24 at Deutsche Bank
MD Mednax
$17.67 /

+0.675 (+3.97%)

MD Mednax
$17.67 /

+0.675 (+3.97%)

Earnings
Quest Diagnostics reports preliminary adj. Q2 EPS $1.39-$1.42 vs. 94c in Q1 » 06:54
07/13/20
07/13
06:54
07/13/20
06:54
DGX

Quest Diagnostics

$116.76 /

+0.93 (+0.80%)

Reports preliminary Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$116.76 /

+0.93 (+0.80%)

DGX Quest Diagnostics
$116.76 /

+0.93 (+0.80%)

06/09/20 Wells Fargo
Quest Diagnostics upgraded to Equal Weight from Underweight at Wells Fargo
06/04/20 JPMorgan
LabCorp price target raised to $223 from $188 at JPMorgan
06/02/20
Fly Intel: Top five analyst upgrades
06/02/20 Deutsche Bank
Quest Diagnostics resumed to Buy from Hold at Deutsche Bank
DGX Quest Diagnostics
$116.76 /

+0.93 (+0.80%)

DGX Quest Diagnostics
$116.76 /

+0.93 (+0.80%)

DGX Quest Diagnostics
$116.76 /

+0.93 (+0.80%)

DGX Quest Diagnostics
$116.76 /

+0.93 (+0.80%)

Hot Stocks
NovaBay: Lab results confirm Avenova kills SARS-CoV-2 » 06:52
07/13/20
07/13
06:52
07/13/20
06:52
NBY

NovaBay

$1.14 /

+ (+0.00%)

NovaBay Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBY NovaBay
$1.14 /

+ (+0.00%)

NBY NovaBay
$1.14 /

+ (+0.00%)

09/18/19 Ladenburg
NovaBay initiated with a Buy at Ladenburg
Hot Stocks
Document Security announces three-year contract valued at $6M per year » 06:50
07/13/20
07/13
06:50
07/13/20
06:50
DSS

Document Security

$7.23 /

-0.76 (-9.51%)

Document Security Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DSS Document Security
$7.23 /

-0.76 (-9.51%)

DSS Document Security
$7.23 /

-0.76 (-9.51%)

06/24/20 Aegis
Document Security assumed with a Buy at Aegis
10/10/19 Aegis
Document Security initiated with a Buy rating at Aegis
DSS Document Security
$7.23 /

-0.76 (-9.51%)

  • 02
    Jul
  • 22
    May
  • 21
    Feb
DSS Document Security
$7.23 /

-0.76 (-9.51%)

Recommendations
Greenbrier price target raised to $25 from $18 at Stephens » 06:49
07/13/20
07/13
06:49
07/13/20
06:49
GBX

Greenbrier

$25.07 /

+3.325 (+15.29%)

Stephens analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

06:17 Today Susquehanna
Greenbrier upgraded to Neutral from Negative at Susquehanna
04/28/20 Susquehanna
Greenbrier downgraded to Negative from Neutral at Susquehanna
04/08/20 KeyBanc
Greenbrier price target lowered to $30 from $38 at KeyBanc
01/14/20 Wells Fargo
Greenbrier downgraded to Underweight from Equal Weight at Wells Fargo
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

Hot Stocks
Lazard reports preliminary AUM approximately $214.7B as of June 30 » 06:48
07/13/20
07/13
06:48
07/13/20
06:48
LAZ

Lazard

$28.24 /

+0.865 (+3.16%)

The month's AUM…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAZ Lazard
$28.24 /

+0.865 (+3.16%)

LAZ Lazard
$28.24 /

+0.865 (+3.16%)

06/22/20 Credit Suisse
Lazard initiated with a Neutral at Credit Suisse
03/25/20 Wolfe Research
Lazard downgraded to Underperform from Peer Perform at Wolfe Research
01/26/20 Keefe Bruyette
Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
01/06/20 Wolfe Research
Lazard upgraded to Peer Perform from Underperform at Wolfe Research
LAZ Lazard
$28.24 /

+0.865 (+3.16%)

LAZ Lazard
$28.24 /

+0.865 (+3.16%)

Periodicals
Yum China mulls secondary listing in Hong Kong, Reuters reports » 06:48
07/13/20
07/13
06:48
07/13/20
06:48
YUMC

Yum China

$51.34 /

-0.145 (-0.28%)

Yum China is considering…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YUMC Yum China
$51.34 /

-0.145 (-0.28%)

YUMC Yum China
$51.34 /

-0.145 (-0.28%)

04/29/20 Daiwa
Yum China upgraded to Outperform from Neutral at Daiwa
02/06/20 Daiwa
Yum China downgraded to Hold from Outperform at Daiwa
10/28/19
Fly Intel: Top five analyst initiations
10/28/19 Jefferies
Yum China initiated with a Buy at Jefferies
YUMC Yum China
$51.34 /

-0.145 (-0.28%)

YUMC Yum China
$51.34 /

-0.145 (-0.28%)

YUMC Yum China
$51.34 /

-0.145 (-0.28%)

YUMC Yum China
$51.34 /

-0.145 (-0.28%)

Recommendations
Carnival price target lowered to $20 from $29 at Wedbush » 06:48
07/13/20
07/13
06:48
07/13/20
06:48
CCL

Carnival

$16.15 /

+1.57 (+10.77%)

Wedbush analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$16.15 /

+1.57 (+10.77%)

CCL Carnival
$16.15 /

+1.57 (+10.77%)

04:59 Today Stifel
Stifel says COVID could be positive for Carnival, sees 50% share upside
07/09/20 Wells Fargo
Carnival price target raised to $12 from $5 at Wells Fargo
06/23/20 Deutsche Bank
Carnival price target raised to $13 from $11 at Deutsche Bank
06/22/20 Redburn
Cruise Lines cut to Neutral at Redburn on signs of weaker demand recovery
CCL Carnival
$16.15 /

+1.57 (+10.77%)

  • 02
    Apr
CCL Carnival
$16.15 /

+1.57 (+10.77%)

CCL Carnival
$16.15 /

+1.57 (+10.77%)

CCL Carnival
$16.15 /

+1.57 (+10.77%)

Hot Stocks
Waddell & Reed reports preliminary AUM $65B as of June 30 » 06:47
07/13/20
07/13
06:47
07/13/20
06:47
WDR

Waddell & Reed

$15.41 /

+0.86 (+5.91%)

Compared to $64B on May…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDR Waddell & Reed
$15.41 /

+0.86 (+5.91%)

WDR Waddell & Reed
$15.41 /

+0.86 (+5.91%)

11/06/19 Citi
Artisan Partners upgraded to Buy from Neutral at Citi
10/22/19 Evercore ISI
Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative
10/22/19 Evercore ISI
UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI
10/22/19 Evercore ISI
Waddell & Reed downgraded to Underperform from In Line at Evercore ISI
WDR Waddell & Reed
$15.41 /

+0.86 (+5.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.